Showing results (671-680 of 866) with videos related to
Sort By:
Pageof 87
European Journal of Cancer (Oxford, England : 1990)|February 10, 2006
Efficacy and tolerability of chemotherapy in elderly patients with advanced oesophago-gastric cancer: A pooled analysis of three clinical trialsM Trumper, P J Ross, D Cunningham, et al.ESMO Gastrointestinal Oncology|February 6, 2026
Impact of nutritional status on pathological response and recurrence-free survival in locally advanced oesophagogastric adenocarcinoma treated with perioperative FLOT therapyK Sugiyama, S Kumar, A Chaudry, et al.European Journal of Cancer (Oxford, England : 1990)|March 31, 2000
Are 18fluorodeoxyglucose positron emission tomography and magnetic resonance imaging useful in the prediction of relapse in lymphoma residual masses?N R Maisey, M E Hill, A Webb, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1993
The non-invasive monitoring of low dose, infusional 5-fluorouracil and its modulation by interferon-alpha using in vivo 19F magnetic resonance spectroscopy in patients with colorectal cancer: a pilot studyM P Findlay, M O Leach, D Cunningham, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2002
A multicentre phase II trial of primary chemotherapy with cisplatin and protracted venous infusion 5-fluorouracil followed by chemoradiation in patients with carcinoma of the oesophagusJ S Waters, D Tait, D Cunningham, et al.British Journal of Cancer|August 11, 2005
Capecitabine and mitomycin C as third-line therapy for patients with metastatic colorectal cancer resistant to fluorouracil and irinotecanG Chong, J L B Dickson, D Cunningham, et al.Lancet (London, England)|August 24, 1991
Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapyA L Jones, A S Hill, M Soukop, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
High-dose melphalan for multiple myeloma: long-term follow-up dataD Cunningham, L Paz-Ares, M E Gore, et al.Clinical Radiology|February 13, 2021
Current and future best practice in imaging, staging, and response assessment for Non-Hodgkin's lymphomas: the Specialist Integrated Haematological Malignancy Imaging Reporting (SIHMIR) paradigm shiftS Zafar, R K Sharma, J Cunningham, et al.Hematological Oncology|November 1, 1990
Decrease in clonogenic tumour cells in bone marrow aspirates from multiple myeloma patients due to the incorporation of cyclophosphamide into treatment with vincristine, adriamycin and methyl prednisoloneJ B Bell, B C Millar, A Montes-Borinaga, et al.Pageof 87